@article{TAU23780,
author = {Young Kwok and Mannat Narang and Jason K. Molitoris},
title = {Salvage prostate brachytherapy after definitive external radiation: tried and now tested},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {Definitive external beam radiation therapy (EBRT) has long been one of the standard treatment modalities for prostate cancer. However, 15–75% of patients will experience a disease recurrence depending on such factors as the risk group, use and length of androgen deprivation therapy (ADT) and radiation dose (1). Approximately 25% of patients with biochemical recurrence will have local clinical disease progression within 5 years (2).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/23780}
}